|
COPS7B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.06240000025326E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27529999996534E-06 |
| Normal-vs-Stage2 |
2.025800E-02 |
| Normal-vs-Stage3 |
6.791300E-04 |
| Normal-vs-Stage4 |
1.195080E-04 |
| Stage1-vs-Stage2 |
9.993200E-01 |
| Stage1-vs-Stage3 |
7.282000E-01 |
| Stage1-vs-Stage4 |
2.693200E-01 |
| Stage2-vs-Stage3 |
8.324000E-01 |
| Stage2-vs-Stage4 |
4.434200E-01 |
| Stage3-vs-Stage4 |
4.497600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.6028999995128E-07 |
| Normal-vs-AfricanAmerican |
3.89360000000449E-05 |
| Normal-vs-Asian |
1.124100E-02 |
| Caucasian-vs-AfricanAmerican |
9.736000E-01 |
| Caucasian-vs-Asian |
7.613600E-01 |
| AfricanAmerican-vs-Asian |
7.925000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52827999999605E-05 |
| Normal-vs-Female |
3.18789999997904E-06 |
| Male-vs-Female |
6.020400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.565300E-04 |
| Normal-vs-Extreme_Weight |
1.153010E-04 |
| Normal-vs-Obese |
2.29729999999817E-05 |
| Normal-vs-Extreme_Obese |
4.942900E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.432200E-01 |
| Normal_Weight-vs-Obese |
5.632400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.698600E-01 |
| Extreme_Weight-vs-Obese |
7.383600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.987800E-01 |
| Obese-vs-Extreme_Obese |
9.437800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.17489999951204E-07 |
| Normal-vs-Age(41-60Yrs) |
1.09080000032513E-07 |
| Normal-vs-Age(61-80Yrs) |
3.84450000000536E-05 |
| Normal-vs-Age(81-100Yrs) |
3.493200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.943900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.019960E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.535950E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.782300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.638000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.980400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.09939998718767E-09 |
| Normal-VS-Type2 PRCC |
2.516400E-01 |
| Normal-VS-KIRP CIMP |
1.163210E-04 |
| Normal-VS-Unclassified PRCC |
4.418700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.23849835837109E-11 |
| Type1 PRCC-VS-KIRP CIMP |
6.938600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.015610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.812400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.620060E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.534400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.980000E-03 |
| Normal-vs-N1 |
1.449170E-04 |
| Normal-vs-N2 |
2.776100E-03 |
| N0-vs-N1 |
6.684000E-02 |
| N0-vs-N2 |
1.040570E-01 |
| N1-vs-N2 |
5.793400E-01 |
|
|
